ArticleDrug design, development and therapy2025

DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling.

Hua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.